Explained: How does Merck’s Covid-19 pill compare to Pfizer’s?


Pfizer Inc and Merck & Co Inc have developed experimental antiviral pills that have shown promising efficacy in trials of adults with COVID-19 who are at high risk of serious illness. Both drugs also are being studied to see if they can prevent infection in people exposed to the virus.

Here is an explanation of the differences in the two pills.

Which of the new pills works better?
Trial figures provided by the two companies suggest that Pfizer has the more effective pill, but they have not yet offered full data.

Pfizer said on Friday trial results showed that its pill reduced the chance of hospitalization or death by 89% in COVID-19 patients at risk for severe illness given the treatment within three days of the onset of symptoms and by 85% when given within five days of onset.